| Date | Title | Description |
| 07.11.2025 | Volpara Now Operates Under Lunit Brand, Advancing a Unified Vision for AI Cancer Intelligence | The rebranding marks the first phase of Lunit's unified global identity, connecting breast health, AI detection, and precision oncology under one name.
SEOUL, South Korea, Nov. 7, 2025 /PRNewswire/ -- Lunit (KRX: 328130), a leading provider... |
| 16.10.2025 | Volpara Earns ACR® Learning Network Vendor Partner Designation | LYNNWOOD, Wash., Oct. 16, 2025 /PRNewswire/ -- Volpara Health has qualified for the American College of Radiology® (ACR®) Learning Network Vendor Partner designation. Volpara Health partnered with one of the latest graduates of the ACR ImPo... |
| 02.07.2025 | Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis | SEOUL, South Korea, July 2, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced a collaboration with Microsoft to accelerate the delivery of AI-powered healthcare sol... |
| 02.06.2025 | BreastScreen Australia Density Reporting Rule is a Critical Step for Women says Volpara Health, the Leader in AI-assisted Breast Density Measurement | Volpara software is used to assess the breast density of more than 1 million Australian women
annually
WELLINGTON, New Zealand, June 2, 2025 /PRNewswire/ -- Volpara Health, a Lunit a company and global leader in software for the early detec... |
| 19.05.2025 | Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition | Building on Volpara's breast health expertise, Lunit strengthens its U.S. presence—now delivering AI-powered breast cancer screening across 200 imaging sites
SEOUL, South Korea, May 19, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading ... |
| 25.04.2025 | Revolutionizing Breast Cancer Detection: SimonMed and Lunit's Groundbreaking Partnership | In the world of medical imaging, innovation is the lifeblood that fuels progress. Recently, SimonMed Imaging, a titan in outpatient medical imaging, announced a partnership with Lunit, a frontrunner in AI-driven cancer diagnostics. This col... |
| 24.04.2025 | SimonMed Imaging Partners with Lunit to Deliver Best-in-Class AI for Breast Cancer Detection | A Major Leap Forward in Patient Health and the Future of Mammography
PHOENIX, April 24, 2025 /PRNewswire/ -- SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to anno... |
| 23.04.2025 | SimonMed Imaging Partners with Lunit to Deploy AI for Breast Cancer Detection | What You Should Know:
– SimonMed Imaging, one of the largest and most advanced outpatient medical imaging providers in the United States, announced a significant partnership with Lunit, a global leader in AI-driven cancer diagnostics and th... |
| 25.03.2025 | The 2025 Sales & Marketing Chapter
Meet Serge
The line-up:
Past events: |
The Sales & Marketing Chapter is led by Movac Operating Partner, Serge van Dam. Serge spent 10 years in mobile banking and payments, principally as Chief Marketing Officer of M-Com, the world’s leading provider of mobile banking platfo... |
| 24.03.2025 | Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence | CANBERRA, Australia, March 24, 2025 /PRNewswire/ -- Volpara Health, a global leader in AI-powered breast health solutions and a subsidiary of Lunit, today announced two major milestones:
Volpara density is now a validated input to the BOADI... |
| 02.03.2025 | Lunit's Bold Moves: Leadership Changes and Groundbreaking AI Research in Cancer Detection | In the fast-paced world of healthcare technology, change is the only constant. Lunit, a South Korean powerhouse in AI-driven cancer diagnostics, is making waves with two significant announcements. The appointment of Craig Hadfield as CEO of... |
| 26.02.2025 | Lunit Announces Leadership Transition at Volpara: Craig Hadfield Appointed CEO | SEOUL, South Korea and WELLINGTON, New Zealand, Feb. 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the appointment of Craig Hadfield as th... |
| 05.02.2025 | CureMetrix and Volpara Health x Lunit Enter Agreement to Expand Access to cmAngio | Enhancing Women's Health: CureMetrix cmAngio is now available to thousands of providers through Volpara SAN DIEGO, CA, UNITED STATES, February 5, 2025 /EINPresswire.com/ -- CureMetrix®, a leader in AI-based solutions for mammography, announ... |
| 03.02.2025 | Lunit Partners with SITC to Launch Exclusive Research Program Featuring Advanced AI Technology for SITC Members | Lunit SCOPE® IO now available to SITC members for AI-powered TME profiling, in a collaborative effort to advance cancer immunotherapy
SEOUL, South Korea, Feb. 3, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered s... |
| 12.12.2024 | New Lunit Study Demonstrates Universal AI Model for Analysis of Immunohistochemistry Images | Research in npj Precision Oncology highlights multi-cohort training approach and accurate analysis of unseen immunohistochemistry data
SEOUL, South Korea, Dec. 12, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered... |
| 09.12.2024 | Lunit Marks Go-Live in Groundbreaking National AI Cancer Screening Program in BreastScreen NSW | Lunit INSIGHT MMG integrated into the clinical workflow of Australia's BreastScreen New South Wales to assist in reading approximately 31,000 mammography exams annually
SEOUL, South Korea, Dec. 9, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ),... |
| 05.12.2024 | Lunit and Volpara Unveiled Unified Ecosystem at RSNA 2024 to Transform Global Cancer Care | Lunit and Volpara revealed a unified Ecosystem at RSNA 2024, featuring AI-powered cancer risk prediction, autonomous report generation, and innovations to transform global cancer care
SEOUL, South Korea, Dec. 5, 2024 /PRNewswire/ -- At this... |
| 25.11.2024 | Lunit to Showcase Research Contributions at RSNA 2024 with Record-Breaking 20 Abstracts | Twenty studies validate AI performance across diverse populations and clinical settings, including award-winning research in emergency radiology
SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of ... |
| 10.11.2024 | The Future of Cancer Care: AI and Yoga Unite for Patient Empowerment | In the realm of cancer care, two distinct yet powerful forces are emerging: artificial intelligence (AI) and yoga. Both are transforming the landscape of treatment and support for patients. As we stand on the brink of a new era in oncology,... |
| 08.11.2024 | Lunit Shows Promise of AI in Predicting Immunotherapy Response for Rare Cancer Patients at SITC 2024 | Study reveals potential of AI-powered tumor microenvironment assessment in predicting treatment outcomes in rare cancer patients receiving pembrolizumab
SEOUL, South Korea, Nov. 8, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provi... |
| 04.11.2024 | Volpara Health Secures $7.3M Contract to Modernize Breast Cancer Screening for U.S. Military | What You Should Know:
– Volpara Health, a global leader in cancer detection software, has been awarded a significant contract with the U.S. Defense Health Agency (DHA) valued at $7.3M over five years.
– The contract will deploy Volpara’s Pa... |
| 25.10.2024 | Volpara Health Surpasses 300 Peer-Reviewed Papers | Milestone reinforces leadership in AI-powered breast cancer detection
WELLINGTON, New Zealand, Oct. 25, 2024 /PRNewswire/ -- Volpara Health, a Lunit company and global leader in artificial intelligence (AI)-powered breast health solutions, ... |
| 24.10.2024 | Bridging the Gap: The Urgent Need for Comprehensive Glaucoma Research in the U.S. | In the vast landscape of American healthcare, some conditions slip through the cracks. Glaucoma is one of them. A silent thief, it steals vision without warning. Dr. Rohit Varma, a leading figure in ophthalmology, has shed light on this iss... |
| 23.10.2024 | Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance | Two new studies show Lunit INSIGHT MMG cuts radiologist workload by 50% in a double reading environment while maintaining or improving screening quality, and predicts cancer risk up to six years in advance
SEOUL, South Korea, Oct. 23, 2024 ... |
| 10.09.2024 | Lunit to Present AI-Analyzed Immune Phenotype Study as Immunotherapy Response Predictor for Advanced Gastric Cancer at ESMO Congress 2024 | Lunit SCOPE IO® demonstrates potential to assess immune phenotype as an AI-powered biomarker for predicting efficacy of Nivolumab plus Chemotherapy in advanced gastric cancer, independent of PD-L1 status
SEOUL, South Korea, Sept. 10, 2024 /... |
| 09.09.2024 | Lunit Joins Roche's Digital Pathology Open Environment to Advance Cancer Biomarker Testing | Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing
SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Lunit (KRX:... |
| 06.08.2024 | Lunit's AI for Tuberculosis Detection Tops in 12-Product Comparative Study | Lancet Digital Health study highlights Lunit INSIGHT CXR as top performer in TB screening, showing promise for improving detection in high-burden settings
SEOUL, South Korea, Aug. 6, 2024 /PRNewswire/ -- Lunit, a leading provider of AI-powe... |
| 10.05.2024 | Diagnostic Imaging for Women Enhances Mammography Quality with AI: Results Presented at ASMIRT 2024 | DARWIN, Australia, May 10, 2024 /PRNewswire/ -- At the Australian Society of Medical Imaging and Radiation Therapy (ASMIRT) conference this week in Darwin, Diagnostic Imaging for Women (difw), together with Volpara Health announced signific... |
| 13.03.2024 | Update on Lunit's Acquisition of Volpara: New Zealand High Court Initial Approval Secured | - Volpara shareholder meeting to be held on April 12, 2024: Culminating the acquisition journey for Lunit, finalization set for May
SEOUL, South Korea, March 13, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered s... |
| 19.12.2023 | Deals in brief: Shopee buys credit arm of Brazil’s Blu, Biorithm and Blue Planet secure funding, multiple China and India deals, and more | Shopee buys Blu’s local credit arm to expand footprint in Brazil
Shopee, one of the leading e-commerce companies in Southeast Asia, has bought the local credit arm of Blu, a Brazilian fintech company, according to The Business Times.
The de... |
| 15.12.2023 | Deals in brief: Rose All Day Cosmetics confirms Series A funding, Velocity Ventures invests in Joyned, Lunit to acquire Volpara, and more | Rose All Day Cosmetics confirms completion of Series A round
Following reports on December 8 regarding Rose All Day Cosmetics (RADC)’s forthcoming completion of its Series A funding round, the Indonesian D2C cosmetics brand has officially c... |
| 07.02.2023 | Onsite Women’s Health and Volpara Health Announce National Partnership | NASHVILLE, Tenn. (PRWEB) February 07, 2023
Onsite Women’s Health, a leading national provider of breast health services, announces partnership with Volpara Health to adopt Volpara® Analytics™, an artificial intelligence (AI) software tool t... |
| 15.02.2022 | Volpara Health Technologies : Bell Potter Presentation | For personal use only
ASX RELEASE
Volpara Bell Potter Presentation
Wellington, NZ, 15 February 2022: Volpara Health Technologies ("Volpara," "the Group," or "the Company"; ASX:VHT), a global health technology s... |
| 19.07.2021 | Volpara Health Grows Patent Collection With Recently Granted European Protection Of Image Quantification | Volpara now holds 98 granted patents across 27 countries
Volpara has recently been granted another patent by the European Patent Office, raising the total number of patents for the New Zealand-based health tech company to 98. This latest pa... |
| 25.06.2021 | Volpara Health Announces Jill Spear As New Executive Vice President Of Sales & Marketing | Breast Imaging Industry Expert will Focus on Expansion of Volpara’s AI-Powered Breast Health Platform
Volpara Health announced Jill Spear as the new Executive Vice President of Sales and Marketing who will drive continued growth for Volpara... |
| 01.02.2021 | Volpara Acquires Breast Cancer Risk Assessment Company CRA Health, LLC. | |
| 19.11.2020 | Volpara Wins Absolute IT Supreme Scale-Ups Award | |
| 19.10.2020 | Volpara Solutions Becomes Volpara Health | |
